Pfizer boosts dividend in wake of drug failure
303018
Pfizer Inc.  on Monday boosted  its quarterly dividend 21 percent after the surprise failure of  its most important experimental drug caused a sell- off in its  shares, and gave its new chief executive additional duties as  chairman.
697549
New drug prospects push shares to a new 52-week high.
436791
Strong sales of key products drove third quarter earnings at Pfizer Inc. up 50 percent, the world&#39;s largest drug company said Wednesday.
574939
Pfizer Inc , the world's biggest drugmaker, on Wednesday reported fourth-quarter results that beat expectations.
411592
It makes sense for the drugmaker to sell millions more shares right now.
484469
Pfizer Inc. shares rebounded on  Tuesday as a study of Alzheimer's patients found that its  arthritis drug Celebrex carried no increased cardiovascular  risks, differing from findings of a study in cancer patients  released last week.
726208
Pfizer Inc.   raised its 2006 profit forecast on Thursday and said  its roster of experimental drugs in late-stage testing could  triple by 2009, sending its shares higher.
337664
Pfizer licenses an ImmuCell development and sends the company's stock skyrocketing.
202222
Stocks were little changed on Friday,  recovering after a sharp early drop on news from Pfizer Inc.  PFE.N that patients in a study showed an increased risk of  heart attacks after taking its popular Celebrex drug.
111721
Pfizer Inc. PFE.N , the world's  largest drug company, on Wednesday said fourth-quarter earnings  rose, helped by strong sales of cholesterol treatment Lipitor  and arthritis drug Celebrex.
584007
Investors reward the drugmaker for positive study results.
21245
Pfizer Inc.&#39;s shares continued to rebound Wednesday, gaining 4 percent during the day&#39;s trading, as industry analysts continued to sort out the most recent studies involving its Celebrex drug.
499909
Pfizer Inc., the world&#39;s biggest drugmaker, may benefit from Merck &amp; Co.&#39;s withdrawal of Vioxx because Pfizer&#39;s competing pain medicine Celebrex hasn&#39;t been linked to increased risk of heart attacks and strokes.
389867
Shares in Pfizer Inc, the world's  biggest drugmaker, fell more than 10 percent in early trade in  Europe on Monday, after news it had scrapped its most important  experimental drug.
724836
WASHINGTON (CBS.MW) - Pfizer shares tumbled more than 17 percent Friday morning after the company said a study of Pfizer&#39;s Celebrex drug for use in treating cancer has demonstrated an increased cardiovascular risk.
365339
Pfizer Inc. , the world's biggest drugmaker, on Wednesday said third-quarter earnings rose on higher sales of key medicines.
624082
Pfizer Inc., the world&#39;s largest drugmaker, said third-quarter earnings jumped 49 percent after merger-related expenses fell and sales of the cholesterol treatment Lipitor rose.